Showing 1 posts of 1 posts found.
The results of another study into the use of hydroxychloroquine in COVID-19 patients has cast further doubts on its effectiveness …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement